At the news
? BULLISHIMPACT 8/10 8-K filed Apr 14, 2026 at 07:35 ET
Johnson & Johnson reported Q1 2026 earnings with adjusted EPS of $2.70, narrowly beating consensus of $2.68, and raised full-year guidance. The company also announced a 3.1% dividend increase, marking its 64th consecutive annual dividend hike.
- Adjusted EPS of $2.70 vs. consensus of $2.68
- Raised full-year 2026 guidance for adjusted EPS to $11.55 at midpoint
- Declared 3.1% dividend increase to $1.34 per share
- Innovative Medicine segment grew 11.2% with strong performance in oncology and neuroscience
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access